Cooper CompaniesCOO
Market Cap: 18.6B
About: CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Employees: 15,000
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
3,908% more repeat investments, than reductions
Existing positions increased: 481 | Existing positions reduced: 12
73% more call options, than puts
Call options by funds: $45.9M | Put options by funds: $26.5M
20% more funds holding in top 10
Funds holding in top 10: 5 [Q4 2023] → 6 (+1) [Q1 2024]
3% more capital invested
Capital invested by funds: $18.3B [Q4 2023] → $18.8B (+$561M) [Q1 2024]
1% less funds holding
Funds holding: 573 [Q4 2023] → 568 (-5) [Q1 2024]
6% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 79
4.06% less ownership
Funds ownership: 97.55% [Q4 2023] → 93.49% (-4.06%) [Q1 2024]
Research analyst outlook
10 Wall Street Analysts provided 1 year price forecasts over the past 6 months
10 analyst ratings
Jefferies Young Li | 23%upside $115 | Buy Upgraded | 16 Jul 2024 |
Piper Sandler Jason Bednar | 23%upside $115 | Overweight Maintained | 3 Jul 2024 |
Baird Jeff Johnson | 27%upside $118 | Outperform Maintained | 31 May 2024 |
Citigroup Joanne Wuensch | 24%upside $116 | Buy Maintained | 3 Apr 2024 |
Redburn Atlantic Issie Kirby | 34%upside $125 | Buy Upgraded | 19 Mar 2024 |